Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
about
Cytotoxic T cell immunity against telomerase reverse transcriptase in humansThe expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissuesIdentification of human cancers deficient in antigen processingOrigins, genetic landscape, and emerging therapies of small cell lung cancerLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionKBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cellsDownregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain.Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reactionHeterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.Selective changes in expression of HLA class I polymorphic determinants in human solid tumorsImmune checkpoint blockade: the hope for immunotherapy as a treatment of lung cancer?Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinomaReduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancerHighly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient miceTissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfectionLysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.A reassessment of the role of B7-1 expression in tumor rejection.HLA expression in human hepatocellular carcinomaDriving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicitySmall Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?Gamma interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiationMolecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.Negative and positive regulation of human leukocyte antigen class I gene transcription in K562 leukemia cells.Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines.Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cellsInhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.
P2860
Q24676613-928718DB-7AE0-4794-A30C-709AF1E614C9Q24676772-BD2841C4-AD5E-43ED-B70B-B8720CEC267EQ24678495-3422E82E-A893-4670-84A3-3417596F666DQ26798218-F44DE611-B536-4123-8CDB-9F9B839F5BEEQ26850218-08AAF689-5F23-4ADC-8721-A00CC37B1685Q28269339-A4F2F39F-03AE-4A19-AD3E-32A6BFED4347Q31148056-8DED62DD-A0E2-456D-AEF1-C200E5173F8DQ33582592-20BACA92-4C3B-4CB9-90EE-4EC21BF93071Q33796247-1CE71892-327F-4380-8B5D-61FD5EA1302CQ33827463-4460857B-B693-44AF-B82B-92E6A7A3A310Q33863979-EB9E5ECE-FD48-4D49-B366-C6F75FC85052Q34301621-F1262826-1B33-4BA3-A7B9-E8FD5E6137DAQ34406469-DFB93CBF-3D51-4A33-8203-EE0484761564Q34565727-699E4899-575D-4B36-B05E-19E9490D4314Q34635843-D313187B-A744-4C51-9A68-75C283D82B6AQ35027111-C451CB5C-429B-48E2-8303-74090F6B6A3EQ35395985-A070C824-F88B-4D78-9045-7E7564E7D967Q35817079-85DBD612-F959-4219-8CE5-F1D679F55557Q35976941-D5D5E553-2FB8-408A-9CC3-DA1062DA887EQ35981896-3259826D-DD9B-43C4-A1E3-9D3703C2216FQ35987503-B349D04B-33E4-45AD-BCE2-E59BD46B8063Q36134480-14D1D228-BBF0-494A-BA4E-286FD1E52FADQ36136052-915FDFD6-BDD0-4355-9F14-6086C75A391CQ36202548-38BFE535-6E21-4916-93F6-282EB44EFB39Q36202885-E41394C9-5796-4F0C-98CC-47922735AFFEQ36352812-51BDF300-8D3D-4C27-A11C-268BCB3966C0Q36354268-EB34B36C-2EB0-484F-AB19-C84A75A67342Q36356745-58858228-1A02-4DE8-909D-88B63BA4523AQ36362670-AB6FE2FC-6B7D-40A9-80E6-59A7191831BEQ36363521-3D16108D-0E58-4A4B-8BE9-E81EBF965805Q36365375-BA333944-14CA-4FEA-B850-99C6EE876914Q36466184-AC93AB65-1CC4-40E5-A960-FC48D69580FEQ36697378-AEF58E09-9338-40D9-A282-A0473D54B7DAQ36811784-E284BBE5-DD0A-416A-9193-EB05ED71581DQ36914167-AB9F0DF4-C358-40EC-AE3C-BB7D3C079572Q36914404-3180D3DE-996B-456B-8DAB-6F282D6C28F7Q36926022-9D95F96D-FCCA-47DF-A82C-EA4B8301F39EQ37398006-402AD3A2-1D03-444C-B656-CC8B12F55D90Q37407917-9430A72B-C4EF-4ABC-8272-4FFCCE7ED91FQ37480901-03AE658A-219F-4F26-995F-BC8F5EBC5BDD
P2860
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Markedly decreased expression ...... human small-cell lung cancer.
@ast
Markedly decreased expression ...... human small-cell lung cancer.
@en
type
label
Markedly decreased expression ...... human small-cell lung cancer.
@ast
Markedly decreased expression ...... human small-cell lung cancer.
@en
prefLabel
Markedly decreased expression ...... human small-cell lung cancer.
@ast
Markedly decreased expression ...... human small-cell lung cancer.
@en
P2093
P2860
P356
P1476
Markedly decreased expression ...... human small-cell lung cancer.
@en
P2093
F Cuttitta
I Linnoila
J Mulshine
S E Martin
W J Martin
P2860
P304
P356
10.1084/JEM.161.5.1135
P407
P577
1985-05-01T00:00:00Z